Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Caribou Biosciences (NASDAQ:CRBU) Trading Near All-Time Low: Third Quarter Loss and Restructuring in Focus

On October 6, 2026, the company announced that its board approved a restructuring on October 2, 2026 while it conducts a process to explore strategic alternatives to maximize stockholder value. The restructuring includes the planned discontinuation ofClinical Trialsand further development of two allogeneic CAR-T …

Nitish Kishor | 06 November 2026

Cemtrex (NASDAQ:CETX) Trading Near All-Time Low: Shares Down 20%, Fiscal Third Quarter Results and Reverse Splits in Focus

Revenue was USD 18,440,210 against USD 16,965,658 a year earlier.Gross Profitwas USD 7,696,790 against USD 7,370,506, and total operating expenses were USD 8,889,932 against USD 8,012,907.

Nitish Kishor | 06 November 2026

Cerenome (NASDAQ:CNSY) Trading Near All-Time Low: Second Quarter Loss and Name Change in Focus

Cerenome is a U.S. healthcare company focused on central nervous system cancers through threeBusinessareas: precision diagnostics, targeted radiopharmaceutical therapeutics and proprietary data analytics. Effective August 3, 2026, it filed an amendment to change its name from Plus Therapeutics.

Nitish Kishor | 06 November 2026

CervoMed (NASDAQ:CRVO) Trading Near All-Time Low: Shares Down 6%, Second Quarter Update and Neflamapimod Partnership Plan in Focus

CervoMed is a clinical-stage company developing treatments for age-related brain disorders. Its lead candidate, neflamapimod, is an oral small molecule that inhibits theAlphaisoform of p38 MAP kinase.

Nitish Kishor | 06 November 2026

Cheetah Net Supply Chain Service (NASDAQ:CTNT) Trading Near All-Time Low: Shares Down 5%, Second Quarter Results and Balance Sheet Expansion in Focus

The filing says the company has been integrating a newly acquired international tradingBusinesswhile developing a new business strategy.

Nitish Kishor | 06 November 2026

Chimera Investment (NYSE:CIM) Trading Near All-Time Low: Shares Down 7%, Third Quarter Loss and HomeXpress in Focus

Chimera reports two segments, Investment Portfolio and Residential Origination. Management describes a platform that brings together mortgage origination through HomeXpress Mortgage, asset management through Palisade and securitization through a conduit called Prism Capital. TotalAssetswere USD 16,709,206 thousand at September 30, 2026, against USD 15,808,542 …

Nitish Kishor | 06 November 2026

Circle8 Group (NASDAQ:CIRC) Trading Near All-Time Low: Shares Down 6%, Second Quarter Loss and Name Change in Focus

On June 29, 2026, the company changed its name from Atlantic International Corp to Circle8 Group Inc. It began trading under theNasdaqticker CIRC on July 2, 2026 and describes itself as a worldwide strategic staffing firm.

Nitish Kishor | 06 November 2026

CISO Global (NASDAQ:CISO) Trading Near All-Time Low: Shares Up 10%, Second Quarter Results and Listing Extension in Focus

Revenue was USD 5,791,488 against USD 6,713,587. Total operating expenses were USD 2,909,850 against USD 3,966,227, and the loss from operations was USD 1,487,086 against USD 2,329,387. The net loss was USD 1,612,705 against USD 3,009,921, and the loss per share was USD 0.04 …

Nitish Kishor | 06 November 2026

Cloudastructure (NASDAQ:CSAI) Trading Near All-Time Low: Shares Down 8%, Second Quarter Results and Reverse Split in Focus

Cloudastructure describes itself as an innovator in cloud-native, AI-powered security solutions that deliver real-time situational awareness to enterprises.

Nitish Kishor | 06 November 2026

Co-Diagnostics (NASDAQ:CODX) Trading Near All-Time Low: Shares Down 5%, Second Quarter Loss and Cash Position in Focus

Co-Diagnostics, a Utah corporation, develops, manufactures and sells reagents used for diagnostic tests that detect and analyze nucleic acid molecules, including DNA and RNA.

Nitish Kishor | 06 November 2026
Support

Hi! How can we help you today?

Loading…